Abbonarsi

Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit - 17/12/20

Doi : 10.1016/j.jpeds.2020.08.035 
Sara N. Salerno, PharmD 1, , Yuting Liao, PharmD 2, , Wesley Jackson, MD, MPH 3, Rachel G. Greenberg, MD, MB, MHS 4, 5, Cameron J. McKinzie, PharmD 2, Ashley McCallister, PharmD, MBA 2, Daniel K. Benjamin, PhD 6, Matthew M. Laughon, MD, MPH 3, Keia Sanderson, MD, MSCR 7, Reese H. Clark, MD 8, Daniel Gonzalez, PharmD, PhD 1,
1 Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 
2 Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 
3 Department of Pediatrics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 
4 Department of Pediatrics, Duke University School of Medicine, Durham, NC 
5 Duke Clinical Research Institute, Durham, NC 
6 Department of Economics, Clemson University, Clemson, SC 
7 Department of Medicine-Nephrology, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 
8 MEDNAX Center for Research, Education, Quality and Safety, Sunrise, FL 

Reprint requests: Daniel Gonzalez, PharmD, PhD, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC 27599-7569UNC Eshelman School of PharmacyThe University of North Carolina at Chapel Hill301 Pharmacy Lane, Campus Box #7569Chapel HillNC27599-7569

Abstract

Objective

To determine the incidence of acute kidney injury (AKI) in infants exposed to nephrotoxic drug combinations admitted to 268 neonatal intensive care units managed by the Pediatrix Medical Group.

Study design

We included infants born at 22-36 weeks gestational age, ≤120 days postnatal age, exposed to nephrotoxic drug combinations, with serum creatinine measurements available, and discharged between 2007 and 2016. To identify risk factors associated with a serum creatinine definition of AKI based on the Kidney Disease: Improving Global Outcomes criteria, we performed multivariable logistic and Cox regression adjusting for gestational age, sex, birth weight, postnatal age, race/ethnicity, sepsis, respiratory distress syndrome, baseline serum creatinine, and duration of combination drug exposure. The adjusted odds of AKI were determined relative to gentamicin + indomethacin for the following nephrotoxic drug combinations: chlorothiazide + ibuprofen; chlorothiazide + indomethacin; furosemide + gentamicin; furosemide + ibuprofen; furosemide + tobramycin; ibuprofen + spironolactone; and vancomycin + piperacillin-tazobactam.

Results

Among 8286 included infants, 1384 (17%) experienced AKI. On multivariable analysis, sepsis, lower baseline creatinine, and duration of combination therapy were associated with increased odds of AKI. Furosemide + tobramycin and vancomycin + piperacillin-tazobactam were associated with a decreased risk of AKI relative to gentamicin + indomethacin in both the multivariable and Cox regression models.

Conclusions

In this cohort, infants receiving longer durations of nephrotoxic combination therapy had an increased odds of developing AKI.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : neonates, drug-drug interactions, acute kidney injury

Abbreviations : AKI, NICU, VLBW


Mappa


 S.S. was supported by the National Institute of General Medical Sciences and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under Award Number 5T32GM086330. M.L. received research support from the National Heart, Lung, and Blood Institute (1K24HL143283). D.G. received research support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (5K23HD083465). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. R.G. has received support from industry for research services (conflict-of-interest/). The other authors declare no conflicts of interest.


© 2020  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 228

P. 213-219 - gennaio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Target-Based Care: An Intervention to Reduce Variation in Postoperative Length of Stay
  • Andrew Y. Shin, Isabelle J. Rao, Hannah K. Bassett, Whitney Chadwick, Joseph Kim, Alaina K. Kipps, Komal Komra, Ling Loh, Katsuhide Maeda, Monica Mafla, Laura Presnell, Paul J. Sharek, Katherine M. Steffen, David Scheinker, Claudia A. Algaze
| Articolo seguente Articolo seguente
  • 50 Years Ago in The Journal of Pediatrics : Congenital Syphilis: A Persistent Problem for Which Management Always Is Perplexing
  • Sarah S. Long

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.